These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3271157)

  • 21. The effects of salicylate on the pharmacokinetics of phenytoin.
    Olanow CW; Finn AL; Prussak C
    Neurology; 1981 Mar; 31(3):341-2. PubMed ID: 7193826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Monitoring therapy by analysis of the drug concentration of saliva].
    Bartels H; Günther E; Wallis S
    Monatsschr Kinderheilkd; 1983 Jan; 131(1):13-6. PubMed ID: 6835213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrantly high phenytoin concentrations in saliva. Precaution in monitoring phenytoin concentrations in whole saliva.
    Paxton JW; Foote S
    Br J Clin Pharmacol; 1979 Nov; 8(5):508-9. PubMed ID: 508560
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of aspirin on salivary and serum phenytoin kinetics in healthy subjects.
    Paxton JW
    Clin Pharmacol Ther; 1980 Feb; 27(2):170-8. PubMed ID: 7353335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Factors involved in gingival hyperplasia caused by diphenyl hydantoin].
    Mattioli A; Mauro S; Menetti L; Orlando S
    Minerva Stomatol; 1997 Oct; 46(10):525-32. PubMed ID: 9432558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe phenytoin-induced gingival enlargement associated with periodontitis.
    Lucchesi JA; Cortelli SC; Rodrigues JA; Duarte PM
    Gen Dent; 2008; 56(2):199-203; quiz 204-5, 224. PubMed ID: 18348382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism of phenytoin by the gingiva of normal humans: the possible role of reactive metabolites of phenytoin in the initiation of gingival hyperplasia.
    Zhou LX; Pihlstrom B; Hardwick JP; Park SS; Wrighton SA; Holtzman JL
    Clin Pharmacol Ther; 1996 Aug; 60(2):191-8. PubMed ID: 8823237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of phenytoin induced gingival overgrowth in epileptic children: a six month evaluation.
    Prasad VN; Chawla HS; Goyal A; Gauba K; Singhi P
    J Indian Soc Pedod Prev Dent; 2002 Jun; 20(2):73-80. PubMed ID: 12435021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Phenytoin and gingival hyperplasia].
    Bostanci H; Aksoy N; Aydin N
    Ankara Univ Hekim Fak Derg; 1987 Sep; 14(3):313-6. PubMed ID: 3507874
    [No Abstract]   [Full Text] [Related]  

  • 30. Gas-chromatographic assay of free phenytoin in ultrafiltrates of plasma: test of a new filtration apparatus and specimen stability.
    Joern WA
    Clin Chem; 1981 Mar; 27(3):417-21. PubMed ID: 7471390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution and metabolism of diphenylhydantoin in oral and nonoral tissues of ferrets.
    Steinberg AD; Allen PM; Jeffay H
    J Dent Res; 1973; 52(2):267-70. PubMed ID: 4511308
    [No Abstract]   [Full Text] [Related]  

  • 32. Salivary phenytoin concentrations.
    Mitchell W; Greenwood RS
    J Pediatr; 1981 Dec; 99(6):1000. PubMed ID: 7310575
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum phenytoin concentration and IgG antibody titre to periodontal bacteria in patients with phenytoin-induced gingival overgrowth.
    Yamada H; Nishimura F; Furuno K; Naruishi K; Kobayashi Y; Takashiba S; Murayama Y
    J Int Acad Periodontol; 2001 Apr; 3(2):42-7. PubMed ID: 12666977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium channel blocker-induced gingival hyperplasia: case report and review of this iatrogenic disease.
    Lawrence DB; Weart CW; Laro JJ; Neville BW
    J Fam Pract; 1994 Nov; 39(5):483-8. PubMed ID: 7964547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gingival hyperplasia after Dilantin].
    Angel E
    Rev Fed Odontol Colomb; 1968; 17(84):31-46. PubMed ID: 5244229
    [No Abstract]   [Full Text] [Related]  

  • 36. Phenytoin hyperplasia occurring in relation to titanium implants: a clinical report.
    Chee WW; Jansen CE
    Int J Oral Maxillofac Implants; 1994; 9(1):107-9. PubMed ID: 8150508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Office management of phenytoin-induced gingival overgrowth.
    Steinberg AD
    Compend Contin Educ Dent (Lawrenceville); 1985 Feb; 6(2):138-42, 145-7. PubMed ID: 3855742
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug formulation and salivary phenytoin measurements.
    Ayers GJ; Burnett D
    Lancet; 1977 Mar; 1(8012):656. PubMed ID: 66462
    [No Abstract]   [Full Text] [Related]  

  • 39. Drugs in dentistry. Medications for gingival hyperplasia.
    Ciancio SG
    Dent Manage; 1987 Nov; 27(11):69-71. PubMed ID: 3479350
    [No Abstract]   [Full Text] [Related]  

  • 40. Diphenylhydantoin gingival hyperplasia: incidence and etiology.
    Zeitler DL; Zach GA
    J Hosp Dent Pract; 1980; 14(1):41-4. PubMed ID: 6964964
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.